drugset / Trial / NCT01565577
Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVac® (Extension MenbVac)
Phase 3
Completed
117 enrolled
University Hospital, Rouen
Dieppe · collabDirection Générale de la Santé, France · collabInstitut Pasteur · collab
NaSingle-groupOpen-labelHealth-services research
Summary
This study aims to estimate the vaccinal immunity four years after four doses of MenbVac in children aged 4-8 years.
Timeline
- Start
- 2012-04
- Primary completion
- 2012-06
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MenBVac | Vaccine | — | — |
Indications
No indication recorded.